SCHEMBL31663558

SCHEMBL31663558

N#Cc1cccc(-c2ccccc2-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 1/20 0.50
GABRB3 P28472 1/20 0.50
GABRA5 P31644 1/20 0.50
GABRA3 P34903 1/20 0.50
L3MBTL1 Q9Y468 4/20 0.43
ADORA2A P29274 3/20 0.43
ADORA1 P30542 3/20 0.43
MAPK1 P28482 1/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
SQOR Q9Y6N5 2/20 0.41
HPGD P15428 4/20 0.41
KMT2A Q03164 4/20 0.41
KDM4E B2RXH2 4/20 0.41
NPSR1 Q6W5P4 4/20 0.41
LMNA P02545 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CSNK2A1 P68400 1/20 0.40
MYC P01106 1/20 0.39
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663620 0.84 GABRG2 (0.67) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL27365154 0.84 ESR2 (0.47) GABRG2GABRB3GABRA5GABRA3HPGD
SCHEMBL31663516 0.84 ESR2 (0.47) GABRG2GABRB3GABRA5GABRA3HPGD
SCHEMBL31663512 0.79 ADORA1 (0.49) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL26553215 0.78 ESR2 (0.39) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL26553221 0.77 GABRG2 (0.39) GABRG2GABRB3GABRA5GABRA3ADORA2A
SCHEMBL25774511 0.77 GABRG2 (0.45) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL565466 0.77 ESR2 (0.50) GABRG2GABRB3GABRA5GABRA3HPGD
SCHEMBL31663547 0.75 KMT2A (0.48) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL23296289 0.74 KMT2A (0.57) GABRG2GABRB3GABRA5GABRA3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 GABRG2 3351/4885GABRB3 2361/4885GABRA5 2984/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 GABRG2 3351/4885GABRB3 2361/4885GABRA5 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.